Indian generics would soon become the backbone of the global HIV response. Within two years, the US launched PEPFAR, the ...

FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.

The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.

Indian pharmaceutical companies are gaining ground in the Chinese market, winning bids to supply bulk generic drugs, including Dapagliflozin for diabetes treatment. Hetero Labs Limited, Cipla Ltd, ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Q3 2025 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

A molecular switch in breast cancer cells reprograms the genetic production line towards tumor growth and stress resistance.

WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for cheaper, "biosimilar" alternatives to biologic drugs in an effort to reduce ...

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

The Food and Drug Administration (FDA) recently announced changes to its policy on when a comparative efficacy study would be required to ...

On October 29, 2025, the U.S. Food and Drug Administration (FDA), in coordination with the Department of Health and Human Services (HHS) and ...

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.